Skip to content

Anesthetic Efficacy and Hemodynamic Effects of Fospropofol Disodium for General Anesthesia Induction in Elderly Patients

Anesthetic Efficacy and Hemodynamic Effects of Fospropofol Disodium for General Anesthesia Induction in Elderly Patients

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500114604
Enrollment
Unknown
Registered
2025-12-15
Start date
2026-01-01
Completion date
Unknown
Last updated
2026-01-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

general anesthesia

Interventions

Sponsors

Beijing Friendship Hospital ,Capital Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
65 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1.Age >= 65 years, regardless of gender; 2.American Society of Anesthesiologists (ASA) physical status classification: I-III; 3.Body Mass Index (BMI): 18.5–30 kg/m^²; 4.Scheduled for elective surgery under general anesthesia, with an estimated duration of surgery exceeding 30 minutes; 5.Voluntarily participated and provided signed informed consent;

Exclusion criteria

Exclusion criteria: 1.Patients with contraindications to general anesthesia or a history of adverse anesthesia events; 2.Patients combined with brain injury, intracranial hypertension, stroke, unstable angina, or myocardial infarction; 3.Patients with respiratory insufficiency, obstructive pulmonary disease, difficult airway, or assessed as difficult intubation (modified Mallampati class III or IV); 4.Patients with uncontrolled diabetes or hypertension; 5.Patients with a history of drug abuse, alcohol abuse, or substance dependence; 6.Patients with abuse or long-term use of anesthetic, sedative, or analgesic medications; 7.Patients with known or suspected allergy or contraindication to any component of the investigational drug or protocol-specified medications (Sufentanil Citrate Injection, Propofol Medium/Long-Chain Fat Emulsion, Remifentanil Hydrochloride for Injection, or Fospropofol Disodium for Injection); 8.Patients with a history of psychiatric disorders; 9.Patients who have participated in any drug clinical trial within 1 month prior to screening; 10.Patients deemed by the investigator to have any other factors unsuitable for trial participation;

Design outcomes

Primary

MeasureTime frame
Success Rate of Anesthesia Induction;

Secondary

MeasureTime frame
Hypotension During Anesthesia Induction;

Countries

China

Contacts

Public ContactLiujiazi Shao

Beijing Friendship Hospital ,Capital Medical University

shaoliujiazi@163.com+86 10 6313 8780

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026